User menu

Liver transplantation for inborn errors of liver metabolism.

Bibliographic reference Sokal, Etienne. Liver transplantation for inborn errors of liver metabolism.. In: Journal of inherited metabolic disease, Vol. 29, no. 2-3, p. 426-30 (2006)
Permanent URL http://hdl.handle.net/2078.1/10613
  1. Cutillo L, Najimi M, Smets F, et al (2006) Safety of living related liver transplantation for progressive familial intrahepatic cholestasis. Pediatr Transplant (in press).
  2. Darwish AA, Sokal E, Stephenne X, et al (2004) Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl 10: 1213–1215.
  3. Fox IJ, Chowdhury JR, Kaufman SS, et al (1998) Treatment of the Crigler–Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338: 1422–1426.
  4. Ganschow R, Grabhorn E, Schulz A, et al (2005) Long-term results of basiliximab induction immunosuppression in paediatric liver transplant recipients. Pediatr Transplant 9: 741–745.
  5. Goncalves I, Hermans D, Chretien D, et al (1995) Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency. J Hepatol 23: 290–294.
  6. Jacquemin E, Hermans D, Myara A, et al (1997) Ursodeoxycholic acid therapy in paediatric patients with progressive familial intrahepatic cholestasis. Hepatology 25: 519–523.
  7. Jain AB, Marcos A, Pokharna R, et al (2005) Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation 80: 1692–1698.
  8. Kaibori M, Egawa H, Inomata Y, et al (1998) Strategy used to overcome graft atrophy in auxiliary partial orthotopic livertransplantation from a living donor for ornithine transcarbamylase deficiency. Transplant Proc 30: 3221–3222.
  9. Leonard JV (1995) The management and outcome of propionic and methylmalonic acidaemia. J Inherit Metab Dis 18: 430–434.
  10. Lerut JP, Ciccarelli O, Sempoux C, et al (2003) Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation. Transpl Int 16: 879–884.
  11. Nagarajan S, Enns GM, Millan MT, et al (2005) Management of methylmalonic acidaemia by combined liver-kidney transplantation. J Inherit Metab Dis 28: 517–524.
  12. Reding R, Gras J, Sokal E, et al (2003) Steroid-free liver transplantation in children. Lancet 362: 2068–2070.
  13. Reding R, Bourdeaux C, Gras J, et al (2004) The paediatric liver transplantation program at the Université catholique de Louvain. Acta Gastroenterol Belg 67: 176–178.
  14. Rela M, Muiesan P, Vilca-Melendez H, et al (1999) Auxiliary partial orthotopic liver transplantation for Crigler–Najjar syndrome type I. Ann Surg 229: 565–569.
  15. Santos Silva EE, Sarles J, Buts JP, et al (1996) Successful medical treatment of severely decompensated Wilson disease. J Pediatr 128: 285–287.
  16. Saudubray JM, Touati G, Delonlay P, et al (1999) Liver transplantation in propionic acidaemia. Eur J Pediatr 158(Supplement 2): S65–S69.
  17. Scheers I, Bachy V, Stephenne X, et al (2005) Risk of hepatocellular carcinoma in liver mitochondrial respiratory chain disorders. J Pediatr 146: 414–417.
  18. Smets F, Sokal EM (2002) Epstein–Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management. Pediatr Transplant 6: 280–287.
  19. Smets F, Bodeus M, Goubau P, et al (2000a) Characteristics of Epstein–Barr virus primary infection in paediatric liver transplant recipients. J Hepatol 32: 100–104.
  20. Smets F, Vajro P, Cornu G, et al (2000b) Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation. Transplantation 69: 982–984.
  21. Smets F, Latinne D, Bazin H, et al (2002) Ratio between Epstein–Barr viral load and anti-Epstein–Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 73: 1603–1610.
  22. Sokal EM, Van Hoof F, Alberti D, et al (1992a) Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis. Eur J Pediatr 151: 200–203.
  23. Sokal EM, Bustos R, Van Hoof F, et al (1992b) Liver transplantation for hereditary tyrosinemia – early transplantation following the patient's stabilization. Transplantation 54: 937–939.
  24. Sokal EM, Lopez-Silvarrey A, Buts JP, et al (1993a) Orthotopic liver transplantation for type I glycogenosis unresponsive to medical therapy. J Pediatr Gastroenterol Nutr 16: 465–467.
  25. Sokal EM, Ulla L, Harvengt C, et al (1993b) Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications. Transplantation 55: 432–433.
  26. Sokal EM, Silva ES, Hermans D, et al (1995) Orthotopic liver transplantation for Crigler–Najjar type I disease in six children. Transplantation 60: 1095–1098.
  27. Sokal EM, Sokol R, Cormier V, et al (1999) Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 158(Supplement 2): S81–S84.
  28. Sokal EM, Smets F, Bourgois A, et al (2003) Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76: 735–738.
  29. Stéphenne X, Najimi M, Smets F, et al (2005) Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant 5: 2058–2061.
  30. Stéphenne X, Najimi M, Sibille C, Nassogne M, Smets F, Sokal EM (2006) Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology (in press).
  31. Strom SC, Chowdhury JR, Fox IJ (1999) Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 19: 39–48.
  32. Van Maldergem L, Moser AB, Vincent MF, et al (2005) Orthotopic liver transplantation from a living-related donor in an infant with a peroxisome biogenesis defect of the infantile Refsum disease type. J Inherit Metab Dis 28: 593–600.
  33. van't Hoff W, McKiernan PJ, Surtees RA, et al (1999) Liver transplantation for methylmalonic acidaemia. Eur J Pediatr 158(Supplement 2): S70–S74.
  34. Verloes A, Temple IK, Hubert AF, et al (1996) Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers. J Med Genet 33: 444–449.
  35. Wanty C, Joomye R, Van Hoorebeek N, et al (2004) Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy. Acta Gastroenterol Belg 67: 313–319.
  36. Wendel U, Saudubray JM, Bodner A, et al (1999) Liver transplantation in maple syrup urine disease. Eur J Pediatr 158(Supplement 2): S60–S64.
  37. Yorifuji T, Kawai M, Mamada M, et al (2004) Living-donor liver transplantation for propionic acidaemia. J Inherit Metab Dis 27: 205–210.